ArticleFrontiers in oncology2025
Clinicopathological and imaging features of struma ovarii: a retrospective study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Article
- Analysis of ultrasound features and clinical manifestations of struma ovarii.Frontiers in oncology · 2026Article
- Recurrent Malignant Struma Ovarii With Peritoneal Implants Following Prior Thyroid Carcinoma Treatment.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The struma ovarii (SO) is a rare disease, presenting significant challenges in achieving an accurate diagnosis. This study aims to delineate the clinicopathological and multimodal imaging characteristics of SO, enabling the precise diagnosis of this entity. Methods: A retrospective analysis was conducted of the clinicopathological manifestations, laboratory examination results, and imaging data (including ultrasound and MRI) of 40 SO patients who received treatment at the First Affiliated Hospital of Ningbo University over the period from January 2010 to February 2024. Results: The pathological results of 40 patients showed 21 pure SO, including 20 benign and one malignant; 19 patients had mixed SO, composed of 17 benign and two malignant. Three malignant cases were thyroid carcinoid. According to the ultrasound image, 40 SO patients were divided into three types: 22 cases were cystic, which had mainly single room or separations; 12 cases were mainly cystic-solid mixed, which had multiple septations and hyperechoic nodules; and six solid cases showed regular or irregular mass and rich blood supply. Five patients underwent contrast-enhanced ultrasound (CEUS) examination. The cystic wall and septation showed equal enhancement and slow regression. Two patients showed low enhancement in the protrusion and with slow regression. The MRI manifestations of SO are various. In this cohort, T1-weighted imaging (T1WI) showed hypo-intensity in six cases and heterogeneity in six cases; T2-weighted imaging (T2WI) showed hypo-intensity in two cases, heterogeneity in five cases, and hyper-intensity in four cases; diffusion-weighted imaging (DWI) showed hypo-intensity in two cases, heterogeneity in three cases, and hyper-intensity in four cases. Conclusions: The incidence of SO is low, but there are some features in imaging. There were cystic, cystic-solid, or solid lesions in the appendage area; CEUS showed separations and solid components with rich blood flow and slow enhancement; MRI showed high signal on T2WI and multiple cysts and heterogeneous signal on T1WI, which were the imaging markers for SO. A comprehensive understanding of imaging manifestations can help radiologists identify this disease and provide a basis for an appropriate therapeutic regime.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.